DVL1 Gene
Introduction
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">DVL1 Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>DVL1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>DVL1</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=DVL1" target="_blank">Search NCBI</a></td>
</tr>
</table>
DVL1 (Dishevelled Segment Polarity Protein 1) is a key cytoplasmic effector of the Wnt signaling pathway that plays critical roles in embryonic development, neuronal differentiation, synapse formation, and adult brain function. As a central component of both canonical (β-catenin-dependent) and non-canonical Wnt pathways, DVL1 integrates extracellular Wnt signals to regulate gene transcription, cytoskeletal dynamics, and cell-cell communication. Mutations in DVL1 cause Robinow syndrome, an autosomal dominant disorder characterized by mesomelic limb shortening, genital hypoplasia, and distinctive facial features. Additionally, dysregulated DVL1 signaling has been implicated in [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and [autism spectrum disorders](/diseases/autism-spectrum-disorder) [1][2].
--- [@macdonald2009]
title: DVL1 Gene [@schwarzromond2007]
--- [@clevers2012]
...DVL1 Gene
Introduction
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">DVL1 Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>DVL1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>DVL1</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=DVL1" target="_blank">Search NCBI</a></td>
</tr>
</table>
DVL1 (Dishevelled Segment Polarity Protein 1) is a key cytoplasmic effector of the Wnt signaling pathway that plays critical roles in embryonic development, neuronal differentiation, synapse formation, and adult brain function. As a central component of both canonical (β-catenin-dependent) and non-canonical Wnt pathways, DVL1 integrates extracellular Wnt signals to regulate gene transcription, cytoskeletal dynamics, and cell-cell communication. Mutations in DVL1 cause Robinow syndrome, an autosomal dominant disorder characterized by mesomelic limb shortening, genital hypoplasia, and distinctive facial features. Additionally, dysregulated DVL1 signaling has been implicated in [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and [autism spectrum disorders](/diseases/autism-spectrum-disorder) [1][2].
--- [@macdonald2009]
title: DVL1 Gene [@schwarzromond2007]
--- [@clevers2012]
.infobox.infix-gene [@avila2020]
; Gene Symbol [@white2015]
: DVL1 [@liu2018]
; Full Name [@inestrosa2014]
: Dishevelled Segment Polarity Protein 1 [@cardozo2009]
; Chromosomal Location [@mineur2017]
: 1p36.33 [@zhang2019]
; NCBI Gene ID
: [1855](https://www.ncbi.nlm.nih.gov/gene/1855)
; OMIM
: [604360](https://www.omim.org/entry/604360)
; Ensembl ID
: [ENSG00000107485](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000107485)
; UniProt ID
: [Q92997](https://www.uniprot.org/uniprotkb/Q92997)
; Associated Diseases
: Alzheimer's Disease, Autism Spectrum Disorder, Robinow Syndrome
Overview
Mermaid diagram (expand to render)
DVL1 encodes a member of the Dishevelled (DVL) protein family, which are key components of the Wnt signaling pathway. DVL1 acts as a positive regulator of canonical Wnt signaling by antagonizing beta-catenin degradation. In [neurons](/entities/neurons), DVL1 localizes to synapses and regulates synaptic formation and function. DVL1 mutations cause Robinow syndrome, an autosomal dominant genetic disorder. Dysregulated DVL1 signaling has been implicated in Alzheimer's disease and autism spectrum disorders.
Protein Structure and Domains
The DVL1 protein contains several conserved domains that mediate protein-protein interactions and signal transduction:
N-Terminal DIX Domain (Axin/Dishevelled Domain)
The DIX domain (approximately 80 amino acids) mediates DVL1 self-association and polymerization, which is essential for signal transduction. This domain allows DVL1 to form cytoplasmic puncta in response to Wnt stimulation [3].
PDZ Domain
The PDZ domain (approximately 90 amino acids) binds to the C-terminal motif of transmembrane receptors and scaffolding proteins, including:
- Frizzled (Fz) receptors
- Van Gogh (Vangl) proteins
- Axin
- Nedu
DEP Domain (Dishevelled, Egl-27, and Plexin)
The DEP domain (approximately 80 amino acids) is required for:
- Membrane localization of DVL1
- Activation of non-canonical Wnt pathways (planar cell polarity)
- Interaction with downstream effectors
C-Terminal Proline-Rich Region
This region contains binding sites for SH3 domain-containing proteins and participates in cytoskeletal regulation.
Molecular Functions
Canonical Wnt/β-Catenin Signaling
In the canonical Wnt pathway, DVL1 acts downstream of Frizzled receptors to inhibit the β-catenin destruction complex (containing GSK3β, APC, Axin, and CK1α). Upon Wnt ligand binding:
DVL1 is recruited to the plasma membrane via interaction with Frizzled receptors
DVL1 polymerizes and sequesters Axin away from the destruction complex
β-Catenin accumulates and translocates to the nucleus
β-Catenin co-activates TCF/LEF transcription factors to express Wnt target genes [4]Non-Canonical Wnt Signaling
DVL1 also participates in β-catenin-independent pathways:
Planar Cell Polarity (PCP) Pathway
- DVL1 regulates cytoskeletal organization via interaction with Daam1, Rac1, and RhoA
- Controls cell polarity and migration during neural tube formation
- Regulates dendritic arborization in neurons
Wnt/Ca²⁺ Pathway
- DVL1 can activate phospholipase C (PLC) and increase intracellular calcium
- Regulates calcium-dependent signaling in neurons
Synaptic Function
DVL1 localizes to both pre- and post-synaptic compartments where it:
- Regulates dendritic spine formation and morphology
- Controls synaptic assembly via interaction with PSD-95
- Modulates synaptic plasticity and [long-term potentiation](/mechanisms/long-term-potentiation) (LTP)
- Participates in [NMDA](/entities/nmda-receptor) receptor trafficking [5]
Expression Pattern
DVL1 is widely expressed in the developing and adult brain:
Developmental Expression
- High expression during embryonic neurogenesis
- Expressed in neural progenitor cells
- Critical for cortical plate formation
Adult Brain Expression
- Cerebral [cortex](/brain-regions/cortex): pyramidal neurons in layers II-VI
- [Hippocampus](/brain-regions/hippocampus): CA1-CA3 pyramidal cells, dentate gyrus granule cells
- Cerebellum: Purkinje cells and granule cells
- Subventricular zone: neural stem cells
- Synapses: both pre-synaptic terminals and post-synaptic densities
Disease Associations
Robinow Syndrome
Heterozygous missense mutations in DVL1 cause autosomal dominant Robinow syndrome, characterized by:
- Mesomelic limb shortening (short forearms and lower legs)
- Genital hypoplasia (hypoplastic genitalia)
- Distinctive facial features (broad nasal bridge, midface retrusion)
- Normal intelligence in most cases
- Occasional vertebral segmentation defects [6][7]
The pathogenic mechanisms involve:
- Dominant-negative effects on Wnt signaling
- Impaired DVL1 polymerization
- Dysregulated transcription of Wnt target genes during embryogenesis
Alzheimer's Disease
Multiple lines of evidence link DVL1 to [Alzheimer's disease](/diseases/alzheimers-disease) pathogenesis:
[Amyloid-Beta](/proteins/amyloid-beta) (Aβ) Regulation
- Wnt signaling is neuroprotective against Aβ toxicity
- DVL1 expression is altered in AD brains and AD mouse models
- Aβ oligomers disrupt Wnt signaling by affecting DVL1 localization
[Tau](/proteins/tau) Pathology
- GSK3β, a key kinase in Wnt signaling, phosphorylates [tau](/proteins/tau)
- DVL1 dysfunction may contribute to tau hyperphosphorylation
- Wnt pathway activation reduces tau pathology in experimental models
Synaptic Dysfunction
- DVL1 is critical for synaptic plasticity
- Wnt pathway deficits contribute to synaptic loss in AD
- DVL1-mediated spine changes are impaired in AD [8]
Parkinson's Disease
In [Parkinson's disease](/diseases/parkinsons-disease):
- Wnt/DVL signaling is dysregulated in the substantia nigra
- Dopaminergic neurons are particularly vulnerable to Wnt pathway disruption
- [LRRK2](/entities/lrrk2) (a PD gene product) interacts with DVL1
- DVL1 dysfunction may contribute to [α-synuclein](/proteins/alpha-synuclein) toxicity [9]
Autism Spectrum Disorder
DVL1 is implicated in [autism spectrum disorders](/diseases/autism-spectrum-disorder) through:
- Synaptic function regulation
- Dendritic spine morphology
- Social behavior and cognitive flexibility
- Interaction with autism-related genes (NRXN1, CNTNAP2) [10]
Cancer
While not a neurodegenerative disease, DVL1 dysregulation is observed in various cancers:
- DVL1 overexpression in colorectal, breast, and lung cancers
- Role in tumor cell proliferation and invasion
- Potential therapeutic target
Therapeutic Implications
Drug Development
Targeting DVL1 and the Wnt pathway for neurodegeneration:
- Wnt pathway activators: Small molecules that enhance DVL1 function
- GSK3β inhibitors: Downstream targets that reduce tau phosphorylation
- Wnt-derived peptides: Mimic Wnt signaling for therapeutic benefit
- Frizzled agonists: Activate upstream of DVL1 [11]
Biomarkers
DVL1 expression changes may serve as:
- Indicators of Wnt pathway dysfunction in neurodegenerative diseases
- Markers of synaptic integrity
- Therapeutic response biomarkers
Research Directions
Ongoing research focuses on:
- Understanding DVL1 mutations in Robinow syndrome
- Elucidating DVL1 functions in specific neuronal subtypes
- Developing Wnt pathway-targeted therapeutics for AD and PD
- Characterizing DVL1 interactions with disease-related proteins
- Single-cell analysis of DVL1 expression in neurodegeneration
Background
The study of Dvl1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See Also
- [Wnt Signaling Pathway](/mechanisms/wnt-signaling-neurodegeneration)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Autism Spectrum Disorder](/diseases/autism-spectrum-disorder)
- [Neurodevelopment](/mechanisms/neurodevelopment)
- [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
- [GSK3 Beta](/mechanisms/gsk3-beta)
- [Beta-Catenin](/proteins/beta-catenin)
Pathway Diagram
The following diagram shows the key molecular relationships involving DVL1 Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)